Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.164EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.164EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.164ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.164ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.164EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.164EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.164ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.164ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.275EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.275EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.275ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.275ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.275EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.275EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.275ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.275ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.58ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.58ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.58EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.58EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.62EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.62ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.62ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.62EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.62EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.80 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.80 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.80 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.80 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.80 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.80 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used